c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Kyntra Bio (KYNB) Q3 Revenue Beats Estimates Amid Phase 2 Trial Termination
GuruFocus | Nov 16, 2026 4:56 PM EST
Related Stocks: KYNB ,
Read original article